U-Frag 500000IU Injection

U-Frag 500000IU injection contains an active component of Urokinase. This medication is used to break down and dissolve blood clots that have formed within blood vessels, helping to restore blood flow and prevent serious complications like pulmonary embolism, deep vein thrombosis (DVT), peripheral arterial thrombosis, acute ischemic stroke, central venous catheter thrombosis and myocardial infarction (heart attack). Deep vein thrombosis (DVT) is the formation of blood clots in a deep vein, often in the legs. Pulmonary embolism (PE) is the blockage of a lung artery by a blood clot that travels from elsewhere in the body. Peripheral arterial thrombosis is the formation of blood clots in peripheral arteries, restricting blood flow to limbs. Acute ischemic stroke is the sudden loss of blood flow to the brain, leading to brain cell damage. Central venous catheter thrombosis formation of a blood clot around a catheter placed in a large vein. Myocardial infarction is damage to the heart muscle due to a blocked coronary artery.

Hypersensitivity reactions, including rash, swelling, difficulty breathing, or rapid heartbeat, can occur with this medication use. Patients require monitoring for allergic symptoms, and medical attention is sought if any signs of hypersensitivity appear. U-Frag 500000IU injection is contraindicated in individuals with active internal bleeding, bleeding disorders, recent brain/spinal/eye surgery, severe uncontrolled hypertension, intracranial neoplasm, bacterial endocarditis, or aneurysm/vascular malformation. These contraindications help ensure the safe use of this medication based on specific medical conditions and risks. U-Frag 500000IU injection may be recommended for use in children and the elderly in specific medical situations, but its use requires a thorough evaluation by healthcare professionals.